glp-1 drugs hair loss and Loss: Does Ozempic, Wegovy, or Tirzepatide Cause Hair Loss? ARE YOU ON A GLP-1

Here, we provide a comprehensive review of the therapeutic potential of incretin mimetics and insulin in AD and PD.

Lifestyle modification and nutrition-based approaches are regarded as the cornerstone strategies for treating pediatric obesity

How to Take PeptideComfort for Best Results

By 2030, the global prevalence of obesity is expected to reach one billion

Use of glucagon-like peptide 1 agonists for weight loss compared with bupropion-naltrexone was associated with an increased risk for pancreatitis, gastroparesis and bowel obstruction but not biliary disease, researchers reported in JAMA

Currently, there are ten classes of orally available pharmacological agents to treat T2DM: 1) sulfonylureas, 2) meglitinides, 3) metformin (a biguanide), 4) thiazolidinediones (TZDs), 5) alpha glucosidase inhibitors, 6) dipeptidyl peptidase IV (DPP-4) inhibitors, 7) bile acid sequestrants, 8) dopamine agonists, 9) sodium-glucose transport protein 2 (SGLT2) inhibitors and 10) oral glucagon like peptide 1 (GLP-1) receptor agonists